SOURCE: Equity Markets Inc

October 11, 2011 09:00 ET

Expert's Economic Outlook, Global - Equity Research on ConocoPhillips and Eli Lilly & Co.

Expert's Economic Outlook, Global - Equity Research on ConocoPhillips and Eli Lilly & Co.

MACAU--(Marketwire - Oct 11, 2011) - Today, announced its research report highlighting ConocoPhillips (NYSE: COP) and Eli Lilly & Co. (NYSE: LLY). Full content and research is available at

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets.'

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

Equity Markets has reviewed ConocoPhillips for its current position within the basic materials industry. ConocoPhillips is an international, integrated energy company. The full research report on ConocoPhillips (NYSE: COP) is available here:

Equity Markets has reviewed Eli Lilly & Co. for its development within the healthcare industry. Eli Lilly and Company discovers, develops, manufactures and sells products in one business segment, pharmaceutical products. It also has an animal health business segment. The Company manufactures and distributes its products through facilities in the United States, Puerto Rico, and 17 other countries. Its products are sold in approximately 125 countries. The full research report on Eli Lilly & Co. (NYSE: LLY) is available here:

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact Information